Epidemiology of Vancomycin-Resistant Enterococci in Canadian Hospitals (CANWARD Study, 2007 to 2013) |
| |
| Authors: | P. J. Simner H. Adam M. Baxter M. McCracken G. Golding J. A. Karlowsky K. Nichol P. Lagacé-Wiens M. W. Gilmour Canadian Antimicrobial Resistance Alliance (CARA) D. J. Hoban G. G. Zhanel |
| |
| Affiliation: | aDiagnostic Services Manitoba, Winnipeg, Manitoba, Canada;bUniversity of Manitoba, Department of Medical Microbiology and Infectious Diseases, Winnipeg, Manitoba, Canada;cNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada |
| |
| Abstract: | Of 1,927 Enterococcus species isolates collected across Canada from 2007 to 2013, 80 (4.2%) were identified as vancomycin-resistant enterococci (VRE). VRE infections during this time tripled in Canadian hospitals, from 1.8% to 6.0% (P = 0.03). All VRE were Enterococcus faecium, with 90% possessing vanA. The prevalence of vanB decreased from 37.5% in 2007 to 0% in 2013 (P < 0.05). The VRE were multidrug resistant, but 70.6%, 86.3%, and 100% were susceptible to doxycycline, linezolid, and daptomycin, respectively. |
| |
| Keywords: | |
|
|
